The Truven Health 50 Top Cardiovascular Hospitals study is an annual, objective, quantitative study that identifies the nation's best providers of cardiovascular care, based on publicly available data and a balanced look at clinical, operational, and financial performance metrics. The study is a part of the Truven Health 100 Top Hospitals® program. Hospitals do not apply, and winners do not pay to market their honor.
2017 Award Winners Announced Nov. 7, 2016
Identified from more than 1,000 U.S. hospitals, our award winners are setting new performance standards for this high-profile service line. And their leadership teams are often inspiring not only their own teams, but also their peers, to find opportunities to deliver better healthcare value.
Our latest study provides key industry insights, including the fact that if all cardiovascular providers performed at the level of this year's winners (when compared to a peer group):
- More than 9,000 additional lives could be saved
- Over 6,000 more heart patients could be complication-free
- More than $1.4 billion could be saved
We based this analysis on Medicare patients; if the same standards were applied to all inpatients, the impact would be even greater.
Specifically, the 2017 50 Top Cardiovascular Hospitals had:
- Significantly higher inpatient survival than nonwinning cardiovascular hospitals (25 to 55 percent higher)
- Fewer patients with complications (20 to 22 percent fewer)
- Higher 30-day survival rates for acute myocardial infarction (AMI) and heart failure (HF), and coronary artery bypass grafting (CABG) patients (0.5 to 1.1 percentage points higher)
- Lower readmission rates for AMI, HF, and CABG patients (0.5 to 1.2 percentage points lower)
- Average lengths of stay for CABG patients that were one day lower (0.3 to 0.5 days lower than the other patient groups)
- $1,200 to $6,100 less in total costs per patient case
New This Year: Trends in Cardiovascular Care
For this year’s study, we added an analysis of trends showing the direction and magnitude of change in heart care over a five-year period, from 2011 to 2015. Findings include:
- Readmission rates for AMI and HF patients showed significant improvement in a large percentage of hospitals (50.5 percent and 39.5 percent improvement, respectively)
- However, for HF patients, more than 16 percent of hospitals had statistically significant increases in 30-day mortality rates
- A strong majority of hospitals held the cost of delivering care to AMI, HF, CABG, and percutaneous coronary intervention patients stable
Our 2018 Cardiovascular study release is planned for Nov., 2017.